Name | MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE "APTEKA N 29" |
|---|
INN | 5707001142 |
|---|
KPP | 570701001 |
|---|
OGRN | 1025701256217 |
|---|
OKPO | 27279964 |
|---|
Address | 303240, Orlovskaya Oblast', r-n Dmitrovskiy, g. Dmitrovsk, ul. Sotsialisticheskaya, d. D.46 |
|---|
Phone | +7 (915) 500-14-54 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 23.08.2002 |
|---|
Registering department | Administratsiya Dmitrovskogo rayona Orlovskoy oblasti |
|---|
|
MUP "APTEKA N 29" (Oryol Oblast; INN 5707001142) was registered on 23 Aug 2002. The company's authorized capital as of July 1, 2012 was 555000 rub. Type of ownership of MUP "APTEKA N 29" - Unitary enterprises based on the principle of economic management. Form of ownership of MUP "APTEKA N 29" - Municipal property. Principal activities of MUP "APTEKA N 29": retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net loss (RAS) of MUP APTEKA N 29 dropped over 2023 3.14 times to 56.00 thousand RUB from 176.00 thousand RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 11.04% to 39.66 million RUB from 44.59 million RUB in 2022; cost of goods sold decreased by 10.95% to 33.95 million RUB from 38.13 million RUB; sales profit made up 92.00 thousand RUB compared to sales loss of 101.00 thousand RUB. 2022
Net loss (RA) of MUP APTEKA N 29 made up 176.00 thousand RUB over 2022 compared to net profit of 86.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 1.30% to 44.59 million RUB from 44.01 million RUB over 2021; cost of goods sold grew by 0.61% to 38.13 million RUB from 37.89 million RUB; sales loss made up 101.00 thousand RUB compared to sales profit of 101.00 thousand RUB. 2021
Net profit (RAS) of MUP APTEKA N 29 grew over 2021 2.61 times to 86.00 thousand RUB from 33.00 thousand RUB over 2020, the company informed. Revenue decreased in the accounting period by 11.65% to 44.01 million RUB from 49.82 million RUB in 2020; cost of goods sold decreased by 10.29% to 37.89 million RUB from 42.24 million RUB; sales profit went up 1.53 times to 101.00 thousand RUB from 66.00 thousand RUB. 2020
Net profit (RAS) of MUP APTEKA N 29 grew over 2020 2.27 times to 34.00 thousand RUB from 15.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period by 21.07% to 49.82 million RUB from 41.15 million RUB over 2019; cost of goods sold grew by 21.54% to 42.24 million RUB from 34.75 million RUB; sales profit made up 67.00 thousand RUB compared to sales loss of 111.00 thousand RUB. 2019
Net profit (RAS) of MUP APTEKA N 29 dropped in 2019 8.40 times to 15.00 thousand RUB from 126.00 thousand RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 8.54% to 41.15 million RUB from 37.91 million RUB over 2018; cost of goods sold grew by 8.04% to 34.75 million RUB from 32.17 million RUB; sales loss decreased by 47.89% to 111.00 thousand RUB from 213.00 thousand RUB. 2018
Net profit (RAS) of MUP APTEKA N 29 grew over 2018 2.57 times to 126.00 thousand RUB from 49.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 19.27% to 37.91 million RUB from 31.79 million RUB over 2017; cost of goods sold grew by 20.03% to 32.17 million RUB from 26.80 million RUB. 2017
Net profit (RAS) of MUP APTEKA N 29 grew over 2017 by 8.89% to 49.00 thousand RUB from 45.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 0.89% to 31.79 million RUB from 31.51 million RUB over 2016; cost of goods sold grew by 0.93% to 26.80 million RUB from 26.55 million RUB; sales profit made up 0 RUB compared to 237.00 thousand RUB. 2016
Net profit (RAS) of MUP APTEKA N 29 dropped in 2016 4.69 times to 45.00 thousand RUB from 211.00 thousand RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 0.76% to 31.51 million RUB from 31.75 million RUB in 2015; cost of goods sold decreased by 0.88% to 26.55 million RUB from 26.79 million RUB; sales profit fell by 4.05% to 237.00 thousand RUB from 247.00 thousand RUB. 2014
Net profit (RAS) of MUP Apteka 29 dropped in 2014 60.50 times to 2.00 thousand RUB from 121.00 thousand RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 7.80% to 28.31 million RUB from 26.26 million RUB over 2013; cost of goods sold grew by 8.27% to 23.60 million RUB from 21.80 million RUB; sales loss made up 62.00 thousand RUB compared to sales profit of 47.00 thousand RUB. 2013
Net profit (RAS) of MUP Apteka 29 grew over 2013 4.17 times to 121.00 thousand RUB from 29.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 11.79% to 26.26 million RUB from 23.49 million RUB over 2012; cost of goods sold grew by 11.03% to 21.80 million RUB from 19.64 million RUB; sales profit made up 47.00 thousand RUB compared to sales loss of 3.00 thousand RUB. 2012
Net profit (RAS) of MUP Apteka 29 dropped in 2012 2.41 times to 29.00 thousand RUB from 70.00 thousand RUB over the same period in 2011, the company informed. Cost of goods sold grew by 15.81% to 19.64 million RUB from 16.96 million RUB; sales loss made up 3.00 thousand RUB compared to sales profit of 65.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|